These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 29188757

  • 1. Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction.
    Poshteh Shirani M, Rezaei B, Khayamian T, Dinari M, Karami K, Mehri-Lighvan Z, Hosseini Shamili F, Ramazani M, Alibolandi M.
    J Biomol Struct Dyn; 2018 Dec; 36(16):4156-4169. PubMed ID: 29188757
    [Abstract] [Full Text] [Related]

  • 2. Ingenious pH-sensitive etoposide loaded folic acid decorated mesoporous silica-carbon dot with carboxymethyl-βcyclodextrin gatekeeper for targeted drug delivery and imaging.
    Shirani MP, Rezaei B, Khayamian T, Dinari M, Shamili FH, Ramezani M, Alibolandi M.
    Mater Sci Eng C Mater Biol Appl; 2018 Nov 01; 92():892-901. PubMed ID: 30184819
    [Abstract] [Full Text] [Related]

  • 3. Folic acid-targeted mesoporous silica nanoparticles for two-photon fluorescence.
    Lebret V, Raehm L, Durand JO, Smaïhi M, Werts MH, Blanchard-Desce M, Méthy-Gonnod D, Dubernet C.
    J Biomed Nanotechnol; 2010 Apr 01; 6(2):176-80. PubMed ID: 20738072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S.
    Nanotechnology; 2011 Nov 11; 22(45):455102. PubMed ID: 22019849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
    Wu Y, Ge P, Xu W, Li M, Kang Q, Zhang X, Xie J.
    Mater Sci Eng C Mater Biol Appl; 2020 Mar 11; 108():110386. PubMed ID: 31923940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X, Zhao Y, Ng KW, Zhao Y.
    Chemistry; 2013 Nov 11; 19(46):15593-603. PubMed ID: 24123533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.